67 related articles for article (PubMed ID: 1291150)
1. [Observation on the phenotypic changes of tumor-infiltrating lymphocytes(TIL) during cultivation in vitro].
Zhang BX
Zhonghua Bing Li Xue Za Zhi; 1992 Oct; 21(5):281-3. PubMed ID: 1291150
[TBL] [Abstract][Full Text] [Related]
2. [The antitumor effects of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro].
Zhang BX
Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):79-81. PubMed ID: 1499075
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
5. [Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2].
Itoh K; Shiiba K; Ebina N; Anzai R; Ouchi A; Matsuno S
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):781-90. PubMed ID: 8377752
[TBL] [Abstract][Full Text] [Related]
6. Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes.
Saris SC; Spiess P; Lieberman DM; Lin S; Walbridge S; Oldfield EH
J Neurosurg; 1992 Mar; 76(3):513-9. PubMed ID: 1738033
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
8. Effects of "moxibustion serum" on proliferation and phenotypes of tumor infiltrating lymphocytes.
Chen Y; Zhao C; Chen H; Qin H; Fang F
J Tradit Chin Med; 2003 Sep; 23(3):225-9. PubMed ID: 14535199
[TBL] [Abstract][Full Text] [Related]
9. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Bukowski RM; Sharfman W; Murthy S; Rayman P; Tubbs R; Alexander J; Budd GT; Sergi JS; Bauer L; Gibson V
Cancer Res; 1991 Aug; 51(16):4199-205. PubMed ID: 1868441
[TBL] [Abstract][Full Text] [Related]
10. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer.
Reome JB; Hylind JC; Dutton RW; Dobrzanski MJ
Clin Immunol; 2004 Apr; 111(1):69-81. PubMed ID: 15093554
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
[TBL] [Abstract][Full Text] [Related]
12. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD45 isoforms in fresh and IL-2-cultured tumor-infiltrating lymphocytes from basal cell carcinoma.
Nguyen QH; Moy RL; Roth MD; Yamamoto R; Tomono S; Dubinett SM
Cell Immunol; 1993 Feb; 146(2):421-30. PubMed ID: 8174180
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition effects of tumor infiltrating lymphocytes from oral cancer on nude mice transplanted tumor established with human tongue carcinoma cell lines].
Liao G; Mao Z; Xu P
Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 May; 33(3):146-8. PubMed ID: 11774415
[TBL] [Abstract][Full Text] [Related]
15. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
[TBL] [Abstract][Full Text] [Related]
16. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.
Lafreniere R; Borkenhagen K; Bryant LD; Ng E; Hayton S
J Biol Response Mod; 1990 Feb; 9(1):53-60. PubMed ID: 2181072
[TBL] [Abstract][Full Text] [Related]
17. Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro.
Burger UL; Chang MP; Nagoshi M; Goedegebuure PS; Eberlein TJ
Ann Surg Oncol; 1996 Nov; 3(6):580-7. PubMed ID: 8915492
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma.
Kawata A; Une Y; Hosokawa M; Uchino J; Kobayashi H
Jpn J Clin Oncol; 1992 Aug; 22(4):256-63. PubMed ID: 1331571
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
Karpati RM; Banks SM; Malissen B; Rosenberg SA; Sheard MA; Weber JS; Hodes RJ
J Immunol; 1991 Mar; 146(6):2043-51. PubMed ID: 1672340
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]